Terlipressin

Short Description:


  • Product Name: Terlipressin
  • Cas No: 14636-12-5
  • Molecular Formula: C52H74N16O15S2
  • Molecular weight: 1227.39 g/mol
  • Sequence: H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 acetate salt
  • Appearance: White powder
  • Application: Acute variceal hemorrhage (esophageal varices), Hepatorenal syndrome, Norepinephrine-resistant septic shock - not yet an approved application
  • Package: According to customer's requirements
  • Product Detail

    Product Tags

    Keywords

    • Teripressin acetate
    • most affordable price
    • CAS# 14636-12-5

    Quick Details

    • ProName: Teripressin
    • CasNo: 14636-12-5
    • Molecular Formula: C52H74N16O15S2
    • Appearance: White powder
    • Application: Acute variceal hemorrhage (esophageal …
    • DeliveryTime: prompt shipment
    • PackAge: According to your needs
    • Port: Shenzhen
    • ProductionCapacity: 2 Kilogram/Month
    • Purity: 98%
    • Storage: 2~8℃,protected from light
    • Transportation: by air
    • LimitNum: 1 Gram

    Superiority

     

    professional peptide manufacturer in china.
    high quality with gmp grade
    large scale with competitive price
    our products include: generic bulk peptide apis, cosmetic peptide, custom peptides and veterinary peptides.

     

    Details

    Molecular Formula:

    C52H74N16O15S2

    Relative Molecular Mass:

    1227.39 g/mol

    CAS-Number:

    14636-12-5 (net)

    Long-term Storage:

    -20 ± 5°C

    Sequence:

    H-Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 acetate salt
    (Disulfide bond)

    Fields of Application:

    Acute variceal hemorrhage (esophageal varices)
    Hepatorenal syndrome
    Norepinephrine-resistant septic shock - not yet an approved application

    Active Substance:

    Terlipressin is a synthetic analog of vasopressin and is used as a vasoactive drug in the management of hypotension.
    Terlipressin represents a prodrug, it is converted to (Lys8)- vasopressin (LVP) after removal of the N-terminal

    triglycine in vivo. Terlipressin has a longer duration of action and a better safety profile than the parent compound LVP.

     

    Company Profile:

    company name:Shenzhen JYMed Technology Co.,Ltd.
    Year Established:2009
    Capital: 89.5 Million RMB
    Main product: Oxytocin Acetate,Vasopressin Acetate,Desmopressin Acetate,Terlipressin acetate, Caspofungin acetate, Micafungin sodium, Eptifibatide acetate, Bivalirudin TFA, Deslorelin Acetate,Glucagon Acetate,Histrelin Acetate,Liraglutide Acetate,Linaclotide  Aceteate ,Degarelix Acetate,Buserelin Acetate,Cetrorelix Acetate,Goserelin
    Acetate, Argireline Acetate, Metrixyl Acetate,Snap-8,…..
    We strive for continuing innovations in new peptide synthesis technology and process optimization, and our technical team have over decade of experience in peptide synthesis.JYM has successfully submitted a lot
    of ANDA peptide APIs and formulated products with CFDA and have more than fourty patents approved.
    Our peptide plant is located in Nanjing, Jiangsu province and it has set up a facility of  30,000 square meters in compliance with cGMP guideline. The manufacture facility has been audited and inspected by both domestic and international clients.
    With its excellent quality, most competitive price and strong technical support, JYM not only has gained recognitions for its products from Research organizations and Pharmaceutical industries, but also become one of the most reliable suppliers of peptides in China,. JYM is dedicated to be one of the world’s leading peptide provider in the near future.

  • Previous:
  • Next:

  • Write your message here and send it to us